495.1K
XNAS Volume
High volume+loss today
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Charych Deborah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Paul Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Tuan Tu Diep | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Arora S. Puneet | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Schwab Andrew J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Annalisa Jenkins Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Arsenault Kaitlyn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Punit Dhillon | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 364 | 412,369 (0%) | 0% | 5.5 | 2,020 | Common Stock |
| Kaitlyn Arsenault | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 43,026 | 167,522 (0%) | 0% | 5.0 | 214,700 | Common Stock |
| Kaitlyn Arsenault | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 190 | 210,548 (0%) | 0% | 5.6 | 1,055 | Common Stock |
| Paul Grayson | Director | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 307 | 345,945 (0%) | 0% | 5.6 | 1,704 | Common Stock |
| Paul Grayson | Director | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 86,244 | 259,701 (0%) | 0% | 5.0 | 430,358 | Common Stock |
| Tuan Tu Diep | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 19,489 | 82,259 (0%) | 0% | 5.0 | 97,250 | Common Stock |
| Tuan Tu Diep | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 85 | 101,748 (0%) | 0% | 5.6 | 472 | Common Stock |
| Kaitlyn Arsenault | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.55 per share. | 15 Nov 2024 | 190 | 209,548 (0%) | 0% | 5.6 | 1,055 | Common Stock |
| Kaitlyn Arsenault | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 43,206 | 166,342 (0%) | 0% | 5.0 | 215,598 | Common Stock |
| Punit Dhillon | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.99 per share. | 15 Nov 2024 | 82,546 | 329,823 (0%) | 0% | 5.0 | 411,905 | Common Stock |
| Paul Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Deborah Charych | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Tuan Tu Diep | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Kaitlyn Arsenault | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Andrew J. Schwab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Punit Dhillon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Andrew J. Schwab | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.60 per share. | 11 Sep 2024 | 36,504 | 1,681,685 (1%) | 0% | 6.6 | 240,926 | Common Stock |
| Andrew J. Schwab | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.60 per share. | 11 Sep 2024 | 214,556 | 8,178,964 (6%) | 0% | 6.6 | 1,416,070 | Common Stock |
| Andrew J. Schwab | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 11 Sep 2024 | 79 | 66,277 (0%) | 0% | 6.1 | 479 | Common Stock |
| Andrew J. Schwab | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 11 Sep 2024 | 2,000 | 1,679,685 (1%) | 0% | 6.1 | 12,120 | Common Stock |
| Andrew J. Schwab | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 11 Sep 2024 | 11,758 | 8,167,206 (6%) | 0% | 6.1 | 71,253 | Common Stock |
| Andrew J. Schwab | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.60 per share. | 11 Sep 2024 | 1,440 | 66,356 (0%) | 0% | 6.6 | 9,504 | Common Stock |
| Puneet S. Arora | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Punit Dhillon | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 26 Aug 2024 | 15,727 | 412,733 (0%) | 0% | - | Common Stock | |
| Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 40,000 | 40,000 | - | - | Director Stock Option (Right to Buy) | |
| Andrew J. Schwab | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 13 Mar 2024 | 450,000 | 8,393,520 (6%) | 0% | 10 | 4,500,000 | Common Stock |